Wolverine Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-119,496
Closed -$14.4M 2035
2023
Q1
$14.4M Buy
119,496
+106,959
+853% +$12.3M 0.17% 153
2022
Q4
$1.44M Sell
12,537
-1,075
-8% -$118K 0.01% 654
2022
Q3
$1.4M Buy
+13,612
New +$1.44M 0.02% 676
2020
Q3
Sell
-34,184
Closed -$3.58M 1842
2020
Q2
$3.58M Buy
+34,184
New +$3.66M 0.04% 274

Other funds holding BSX.PRA

Wolverine Asset Management's BSX.PRA Position: Q2 2023 in Review

Wolverine Asset Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 119,496 shares — an estimated $14.4M sold.

Wolverine Asset Management first reported a position in BSX.PRA in Q2 2020 and held it in 4 quarters. The position peaked at $14.4M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Wolverine Asset Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 119,496 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $14.4M.
  • Wolverine Asset Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 4 quarters.
  • Wolverine Asset Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $14.4M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.